Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-11-23, Stock:ABBV, The news for the past five days is as follows:
2018-11-15: NEWS1: After Hours Most Active for Nov 15, 2018 :  QQQ, T, MSFT, GE, INTC, NVDA, ABBV, DWDP, HAL, FCX, CSCO, AMD.NEWS2: After Hours Most Active for Nov 15, 2018 :  QQQ, T, MSFT, GE, INTC, NVDA, ABBV, DWDP, HAL, FCX, CSCO, AMD.NEWS3: ABBVIE LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 in AbbVie, Inc. to Contact the Firm.NEWS4: Exploring Clovis Oncology’s Operational Performance.NEWS5: Understanding Clovis Oncology’s Gross Margin Trend.NEWS6: The Daily Biotech Pulse: FDA Nod For Mallinckrodt's Pain Drug, AbbVie-Neurocrine Report Positive Elagolix Results.NEWS7: AbbVie (ABBV) Gains As Market Dips: What You Should Know.NEWS8: AbbVie (ABBV) Gains As Market Dips: What You Should Know.NEWS9: SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AbbVie Inc. of Class Action Lawsuit and Upcoming Deadline – ABBV.
2018-11-16: NEWS1: WeissLaw LLP: AbbVie Inc. is the Subject of a Legal Investigation.NEWS2: Momenta Moves On.NEWS3: Momenta Moves On.NEWS4: The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of COCP, ABBV, CHGG, HON and DY.NEWS5: DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against AbbVie Inc. (ABBV) & Lead Plaintiff Deadline - November 20, 2018.NEWS6: Gauging Analysts’ Views on Clovis Stock.NEWS7: 11 NYSE- And NASDAQ-Listed Stocks With Cannabis Exposure.NEWS8: Pharma Stock Roundup: FDA Updates on MRK, AZN&apos;s Cancer Drugs, Bayer&apos;s Q3 Earnings.
2018-11-19: NEWS1: Vertex (VRTX) Gets Positive CHMP Opinion for Orkambi in Kids.NEWS2: Vertex (VRTX) Gets Positive CHMP Opinion for Orkambi in Kids.NEWS3: Vertex (VRTX) Gets Positive CHMP Opinion for Orkambi in Kids.NEWS4: CLASS ACTION UPDATE for ABBV and ALNY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders.NEWS5: DEADLINE TUESDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AbbVie Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm.NEWS6: Should Value Investors Consider AbbVie (ABBV) Stock Now?.NEWS7: Should Value Investors Consider AbbVie (ABBV) Stock Now?.NEWS8: Should Value Investors Consider AbbVie (ABBV) Stock Now?.NEWS9: DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against AbbVie Inc. (ABBV) & Lead Plaintiff Deadline – November 20, 2018.NEWS10: How Is Bausch Health’s Ortho Dermatologics Performing?.
2018-11-20: NEWS1: AbbVie (ABBV) Stock Moves -1.55%: What You Should Know.NEWS2: 3 Top Large-Cap Stocks to Buy in November.NEWS3: 3 Top Large-Cap Stocks to Buy in November.NEWS4: 3 Top Large-Cap Stocks to Buy in November.NEWS5: Why Has AstraZeneca’s Stock Price Increased in 2018?.NEWS6: SHAREHOLDER ALERT: ABBV JT CWH HON DY RYAAY: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines.NEWS7: DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AbbVie Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm.NEWS8: FINAL DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against AbbVie Inc. (ABBV) & Lead Plaintiff Deadline - November 20, 2018.NEWS9: AbbVie to Highlight Breadth of Innovative Science and Ongoing Commitment to Blood Cancer Patients with New Data From Studies of Ibrutinib and Venetoclax at 2018 American Society of Hematology Annual Meeting & Exposition.NEWS10: Today's Research Reports on Trending Tickers: AstraZeneca and AbbVie.
2018-11-21: NEWS1: AbbVie (ABBV) Shares Cross 5% Yield Mark.NEWS2: AbbVie (ABBV) Shares Cross 5% Yield Mark.NEWS3: AbbVie Receives US FDA Accelerated Approval for VENCLEXTA® (venetoclax) for Treatment of Newly-Diagnosed Acute Myeloid Leukemia Patients Ineligible for Intensive Chemotherapy.NEWS4: The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ABBV, MGTI, ACHC, JT and HTHT.NEWS5: AbbVie (ABBV) Stock Moves -1.55%: What You Should Know.NEWS6: AbbVie (ABBV) Stock Moves -1.55%: What You Should Know.

Answer: Decrease